RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION
The article discusses the first results of a pharmacoeconomic analysis of the efficacy of using the Pneumococcal conjugated 7-valent vaccine (PCV7) for immunization of children aged 2 months to 5 years in Russia using techniques for modeling various approaches to cohort immunization. It shows clinic...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2009-12-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695674825703424 |
|---|---|
| author | A.A. Baranov V.V. Omel'yanovskii N.I. Briko Yu.V. Lobzin L.S. Namazova-Baranova V.K. Tatochenko S.M. Kharit S.V. Sidorenko I.S. Koroleva A.E. Platonov G.Yu. Moisyak I.S. Krysanov O.I. Ivakhnenko F.M. Tsfasman |
| author_facet | A.A. Baranov V.V. Omel'yanovskii N.I. Briko Yu.V. Lobzin L.S. Namazova-Baranova V.K. Tatochenko S.M. Kharit S.V. Sidorenko I.S. Koroleva A.E. Platonov G.Yu. Moisyak I.S. Krysanov O.I. Ivakhnenko F.M. Tsfasman |
| author_sort | A.A. Baranov |
| collection | DOAJ |
| description | The article discusses the first results of a pharmacoeconomic analysis of the efficacy of using the Pneumococcal conjugated 7-valent vaccine (PCV7) for immunization of children aged 2 months to 5 years in Russia using techniques for modeling various approaches to cohort immunization. It shows clinical and economic efficacy of implementing routine immunization in children during first 5 years against pneumococcal infection using PCV7 given direct and indirect costs. It justifies the expediency of incorporating vaccination against pneumococcal infection in children aged 2 months up into the Russian National Immunization Schedule.Key words: pharmacoeconomic analysis, children during first 5 years of life, vaccination, pneumococcal conjugated 7-valent vaccine |
| format | Article |
| id | doaj-art-1d1cfaaf1ca14e88935a506f8de5ce17 |
| institution | DOAJ |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2009-12-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-1d1cfaaf1ca14e88935a506f8de5ce172025-08-20T03:19:42ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892009-12-0166611931RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATIONA.A. Baranov0V.V. Omel'yanovskii1N.I. Briko2Yu.V. Lobzin3L.S. Namazova-Baranova4V.K. Tatochenko5S.M. Kharit6S.V. Sidorenko7I.S. Koroleva8A.E. Platonov9G.Yu. Moisyak10I.S. Krysanov11O.I. Ivakhnenko12F.M. Tsfasman13Scientific Center of Children’s Health of Russian Academy of Medical Sciences, MoscowScientific Research Institute of Clinicoeconomic Expertize and Pharmacoeconomics SI HPE RSMU, MoscowScientific Center of Children’s Health of Russian Academy of Medical Sciences, MoscowFSHI Scientific Research Institute of Children Infections FMBA, St. PeterburgScientific Center of Children’s Health of Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health of Russian Academy of Medical Sciences, MoscowFSHI Scientific Research Institute of Children Infections FMBA, St. PeterburgFSHI Scientific Research Institute of Children Infections FMBA, St. PeterburgFHI Central Research Institute of Epidemiology, MoscowFHI Central Research Institute of Epidemiology, MoscowScientific Research Institute of Clinicoeconomic Expertize and Pharmacoeconomics SI HPE RSMU, MoscowScientific Research Institute of Clinicoeconomic Expertize and Pharmacoeconomics SI HPE RSMU, MoscowScientific Research Institute of Clinicoeconomic Expertize and Pharmacoeconomics SI HPE RSMU, MoscowScientific Research Institute of Clinicoeconomic Expertize and Pharmacoeconomics SI HPE RSMU, MoscowThe article discusses the first results of a pharmacoeconomic analysis of the efficacy of using the Pneumococcal conjugated 7-valent vaccine (PCV7) for immunization of children aged 2 months to 5 years in Russia using techniques for modeling various approaches to cohort immunization. It shows clinical and economic efficacy of implementing routine immunization in children during first 5 years against pneumococcal infection using PCV7 given direct and indirect costs. It justifies the expediency of incorporating vaccination against pneumococcal infection in children aged 2 months up into the Russian National Immunization Schedule.Key words: pharmacoeconomic analysis, children during first 5 years of life, vaccination, pneumococcal conjugated 7-valent vaccinehttps://www.pedpharma.ru/jour/article/view/936 |
| spellingShingle | A.A. Baranov V.V. Omel'yanovskii N.I. Briko Yu.V. Lobzin L.S. Namazova-Baranova V.K. Tatochenko S.M. Kharit S.V. Sidorenko I.S. Koroleva A.E. Platonov G.Yu. Moisyak I.S. Krysanov O.I. Ivakhnenko F.M. Tsfasman RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION Педиатрическая фармакология |
| title | RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION |
| title_full | RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION |
| title_fullStr | RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION |
| title_full_unstemmed | RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION |
| title_short | RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION |
| title_sort | results of the pharmacoeconomic analysis of the use of a pneumococcal conjugated 7 valent vaccine for prevention of pneumococcal infections in children during first 5 years of life in the russian federation |
| url | https://www.pedpharma.ru/jour/article/view/936 |
| work_keys_str_mv | AT aabaranov resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT vvomelyanovskii resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT nibriko resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT yuvlobzin resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT lsnamazovabaranova resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT vktatochenko resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT smkharit resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT svsidorenko resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT iskoroleva resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT aeplatonov resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT gyumoisyak resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT iskrysanov resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT oiivakhnenko resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation AT fmtsfasman resultsofthepharmacoeconomicanalysisoftheuseofapneumococcalconjugated7valentvaccineforpreventionofpneumococcalinfectionsinchildrenduringfirst5yearsoflifeintherussianfederation |